Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Abstract B016: Genomic features of the tumor microenvironment and antigen presentation machinery vary by clinical and molecular subtypes of breast cancer

Constandina E O'Connell, Yoon Jin Cha, Alexander V Lobanov, Cheng Fan, Brooke M Felsheim, Aranzazu Fernandez-Martinez, Charles M Perou

Cancer Res (2025) 85 (5_Supplement): B016.

https://doi.org/10.1158/1538-7445.GENFUNC25-B016

Published: 11 March 2025

View articletitled, Abstract B016: Genomic features of the tumor microenvironment and antigen presentation machinery vary by clinical and molecular subtypes of breast cancer

Journal Articles

Abstract A012: Mre11 mediates cGAS activation and tumor suppression through ZBP1-dependent necroptosis in breast cancer

Cancer Res (2024) 84 (1_Supplement): A012.

https://doi.org/10.1158/1538-7445.DNAREPAIR24-A012

Published: 09 January 2024

View articletitled, Abstract A012: Mre11 mediates cGAS activation and tumor suppression through ZBP1-dependent necroptosis in breast cancer

Journal Articles

Abstract 5988: A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state

Cheng-fan Lee, Michael Loycano, Luke LOFTUS, Laurie Kostecka, Melvin Li, Sarah Amend, Kenneth Pienta

Cancer Res (2023) 83 (7_Supplement): 5988.

https://doi.org/10.1158/1538-7445.AM2023-5988

Published: 04 April 2023

View articletitled, Abstract 5988: A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state

Journal Articles

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Chengheng Liao, Wentong Fang, Rachel Shi, Jeremy Simon, Travis Ptacek, Giada Zurlo, Youqiong Ye, Leng Han, Cheng Fan, Lei Bao, Christopher Llynard Ortiz, Hong-Rui Lin, Ujjawal Manocha, Weibo Luo, Yan Peng, William Y Kim, Lee-Wei Yang, Qing Zhang

Cancer Res (2023) 83 (5_Supplement): P4-08-23.

https://doi.org/10.1158/1538-7445.SABCS22-P4-08-23

Published: 01 March 2023

View articletitled, Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Journal Articles

Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial

Cancer Res (2022) 82 (12_Supplement): CT026.

https://doi.org/10.1158/1538-7445.AM2022-CT026

Published: 15 June 2022

View articletitled, Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial

Journal Articles

Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics

Sonam Bhatia, Melissa Kramer, Suzanne Russo, Payal Naik, Gayatri Arun, Kyle Brophy, Peter Andrews, Cheng Fan, Charles M. Perou, Jonathan Preall, Taehoon Ha, Dennis Plenker, David A. Tuveson, Arvind Rishi, John E. Wilkinson, W. Richard McCombie, Karen Kostroff, David L. Spector

Cancer Res (2022) 82 (7): 1174–1192.

https://doi.org/10.1158/0008-5472.CAN-21-2807

Published: 01 April 2022

View articletitled, Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics

Includes: Supplementary data

Journal Articles

Abstract PD9-03: Pam50 intrinsic subtype and risk of recurrence score (ROR) for the prediction of endocrine (ET) sensitivity and pathologic response to chemotherapy in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) in the alternate trial (Alliance A011106)

Cancer Res (2022) 82 (4_Supplement): PD9-03.

https://doi.org/10.1158/1538-7445.SABCS21-PD9-03

Published: 15 February 2022

View articletitled, Abstract PD9-03: Pam50 intrinsic subtype and risk of recurrence score (ROR) for the prediction of endocrine (ET) sensitivity and pathologic response to chemotherapy in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) in the alternate trial (Alliance A011106)

Journal Articles

Abstract P5-05-01: Metabolite profiling and RNA-seq identifies novel metabolomic-genomic biomarker and therapeutic options for rapidly proliferating breast cancers

Cherise R Glodowski, Chengheng Liao, Cheng Fan, Juan Liu, Kevin R Mott, Akash Kaushik, Hieu Vu, Jason W Locasale, Samuel K McBrayer, Ralph J DeBerardinis, Charles M Perou, Qing Zhang

Cancer Res (2022) 82 (4_Supplement): P5-05-01.

https://doi.org/10.1158/1538-7445.SABCS21-P5-05-01

Published: 15 February 2022

View articletitled, Abstract P5-05-01: Metabolite profiling and RNA-seq identifies novel metabolomic-genomic biomarker and therapeutic options for rapidly proliferating breast cancers

Journal Articles

Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers

Chengheng Liao, Cherise Ryan Glodowski, Cheng Fan, Juan Liu, Kevin R. Mott, Akash Kaushik, Hieu Vu, Jason W. Locasale, Samuel K. McBrayer, Ralph J. DeBerardinis, Charles M. Perou, Qing Zhang

Cancer Res (2022) 82 (4): 665–680.

https://doi.org/10.1158/0008-5472.CAN-21-2745

Published: 15 February 2022

View articletitled, Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers

Includes: Supplementary data

Journal Articles

Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD

Hsin-Fang Tu, Chun-Jung Ko, Ching-Tai Lee, Cheng-Fan Lee, Shao-Wei Lan, Hsin-Hsien Lin, Hsin-Ying Lin, Chia-Chi Ku, Der-Yen Lee, I-Chun Chen, Ya-Hui Chuang, Francisco Del Caño-Ochoa, Santiago Ramón-Maiques, Chao-Chi Ho, Ming-Shyue Lee, Geen-Dong Chang

Cancer Res (2021) 81 (12): 3270–3282.

https://doi.org/10.1158/0008-5472.CAN-20-3436

Published: 15 June 2021

View articletitled, Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD

Includes: Supplementary data

Journal Articles

Abstract PD15-10: Identification of BBOX1 as a therapeutic target in triple-negative breast cancer

Chengheng Liao, Yang Zhang, Cheng Fan, Laura E. Herring, Juan Liu, Jason W. Locasale, Mamoru Takada, Jin Zhou, Giada Zurlo, Lianxin Hu, Jeremy M. Simon, Travis S. Ptacek, Victor G. Andrianov, Einars Loza, Yan Peng, Huanghe Yang, Charles M. Perou, Qing Zhang

Cancer Res (2021) 81 (4_Supplement): PD15-10.

https://doi.org/10.1158/1538-7445.SABCS20-PD15-10

Published: 15 February 2021

View articletitled, Abstract PD15-10: Identification of BBOX1 as a therapeutic target in triple-negative breast cancer

Journal Articles

Abstract PD9-03: Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival

Jonathan H Shepherd, Terry Hyslop, Cheng Fan, Aranzazu Fernandez Martinez, Joel Parker, Katherine Hoadley, Zhiyuan Hu, Yun Li, Matthew Soloway, Patricia Spears, Ann Partridge, William Sikov, Lisa A Carey, Charles M Perou

Cancer Res (2021) 81 (4_Supplement): PD9-03.

https://doi.org/10.1158/1538-7445.SABCS20-PD9-03

Published: 15 February 2021

View articletitled, Abstract PD9-03: Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival

Journal Articles

Abstract P4-05-12: Genetic determinants of the molecular portraits of epithelial cancers

Youli Xia, Cheng Fan, Katherine A Hoadley, Joel S Parker, Charles M Perou

Cancer Res (2020) 80 (4_Supplement): P4-05-12.

https://doi.org/10.1158/1538-7445.SABCS19-P4-05-12

Published: 15 February 2020

View articletitled, Abstract P4-05-12: Genetic determinants of the molecular portraits of epithelial cancers

Journal Articles

Abstract A081: Activation of sphingosine kinase 1 by lipopolysaccharide promotes prostate cancer cell invasion via matriptase

Cheng-Fan Lee, Benjamin Chen, Jer-Tsong Hsieh, Ming-Shyue Lee

Cancer Res (2018) 78 (16_Supplement): A081.

https://doi.org/10.1158/1538-7445.PRCA2017-A081

Published: 14 August 2018

View articletitled, Abstract A081: Activation of sphingosine kinase 1 by lipopolysaccharide promotes prostate cancer cell invasion via matriptase

Journal Articles

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Cancer Res (2017) 77 (13): 3540–3550.

https://doi.org/10.1158/0008-5472.CAN-16-3556

Published: 02 July 2017

View articletitled, Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Includes: Supplementary data

Journal Articles

Abstract 3119: Identification of genetic drivers in HER2enriched/HER2negative breast cancer

Susana Garcia Recio, Cheng Fan, Marni Siegel, Joel S. Parker, Gina N. Duronio, Aleix Prat, Charles M. Perou

Cancer Res (2017) 77 (13_Supplement): 3119.

https://doi.org/10.1158/1538-7445.AM2017-3119

Published: 01 July 2017

View articletitled, Abstract 3119: Identification of genetic drivers in HER2enriched/HER2negative breast cancer

Journal Articles

Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers

Campbell D. Lawson, Cheng Fan, Natalia Mitin, Nicole M. Baker, Samuel D. George, David M. Graham, Charles M. Perou, Keith Burridge, Channing J. Der, Kent L. Rossman

Cancer Res (2016) 76 (13): 3826–3837.

https://doi.org/10.1158/0008-5472.CAN-15-2923

Published: 30 June 2016

View articletitled, Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers

Includes: Supplementary data

Journal Articles

Abstract 2139: Wild type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL8 secretion via JAK2 activation

Ze-Yi Zheng, Wen Bu, Lin Tian, Cheng Fan, Xia Gao, Cuijuan Yu, Liu Jun, Xiaomei Zhang, Yi-Hua Liao, Yi Li, Michael T. Lewis, Dean Edwards, Susan G. Hilsenbeck, Daniel Medina, Thomas P. Zwaka, Charles M. Perou, Chad J. Creighton, Xiang Zhang, Eric C. Chang

Cancer Res (2015) 75 (15_Supplement): 2139.

https://doi.org/10.1158/1538-7445.AM2015-2139

Published: 01 August 2015

View articletitled, Abstract 2139: Wild type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL8 secretion via JAK2 activation

Journal Articles

Abstract P4-05-01: Genetic analysis of the role of Brca1 in suppression of basal-like breast cancer

Xin-Hai Pei, Feng Bai, Ho Lam Chan, Alexandria Scott, Matthew D Smith, Cheng Fan, Jason I Herschkowitz, Charles M Perou, Alan S Livingstone, David J Robbins, Anthony J Capobianco

Cancer Res (2015) 75 (9_Supplement): P4-05-01.

https://doi.org/10.1158/1538-7445.SABCS14-P4-05-01

Published: 01 May 2015

View articletitled, Abstract P4-05-01: Genetic analysis of the role of Brca1 in suppression of basal-like breast cancer

Journal Articles

BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development

Feng Bai, Ho Lam Chan, Alexandria Scott, Matthew D. Smith, Cheng Fan, Jason I. Herschkowitz, Charles M. Perou, Alan S. Livingstone, David J. Robbins, Anthony J. Capobianco, Xin-Hai Pei

Cancer Res (2014) 74 (21): 6161–6172.

https://doi.org/10.1158/0008-5472.CAN-14-1119

Published: 30 October 2014

View articletitled, BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B016: Genomic features of the tumor microenvironment and antigen presentation machinery vary by clinical and molecular subtypes of breast cancer

Abstract A012: Mre11 mediates cGAS activation and tumor suppression through ZBP1-dependent necroptosis in breast cancer

Abstract 5988: A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial

Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics

Abstract P5-05-01: Metabolite profiling and RNA-seq identifies novel metabolomic-genomic biomarker and therapeutic options for rapidly proliferating breast cancers

Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers

Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD

Abstract PD15-10: Identification of BBOX1 as a therapeutic target in triple-negative breast cancer

Abstract PD9-03: Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival

Abstract P4-05-12: Genetic determinants of the molecular portraits of epithelial cancers

Abstract A081: Activation of sphingosine kinase 1 by lipopolysaccharide promotes prostate cancer cell invasion via matriptase

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Abstract 3119: Identification of genetic drivers in HER2enriched/HER2negative breast cancer

Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers

Abstract 2139: Wild type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL8 secretion via JAK2 activation

Abstract P4-05-01: Genetic analysis of the role of Brca1 in suppression of basal-like breast cancer

BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only